Announced Fri, 26 Jun · 15:09 IST
Entero Healthcare reappoints 2 independent directors, allots ESOP shares
Management Changes View source PDF
ENTERO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.8%1-day move
₹1180.00
prior close
₹1178.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-0.8-1.1-0.4+0.8+0.4+1.3+2.7+0.8+0.0+1.7———
Up moveDown movePending
AI summary
Entero Healthcare's Board approved reappointment of Mr. Rajesh Shashikant Dalal and Ms. Sandhya Gadkari Sharma as Non-Executive Independent Directors for a second term of 4 years each, from August 25, 2026 to August 24, 2030. The Board also allotted 1,475 equity shares at Rs 804 each to an eligible employee under the ESOP 2023 plan. Total issued shares now stand at 4,35,23,072.
Likely market impact
Board continuity secured for 4 more years. Minor equity dilution of 1,475 shares under ESOP is negligible. Neutral to positive for governance.